News - Amorchem

February 15, 2023 AmorChem Promotes Dr. Kevin McBride to General Partner Read article

March 15, 2022 Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial Read article

January 12, 2022 CQDM partners with Neurasic Therapeutics, HBHL and the Louise and Alan Edwards Foundation to fund a non-opioid pain treatment discovery Read article

May 19, 2021 Giiant Pharma Inc. announced the closing of US$11M in Seed financing to develop its Precision Delivery technology platform in gastroenterology. Read article

June 4, 2020 AmorChem invests in a potential treatment for cerebral amyloid angiopathy and Alzheimer’s disease Read article

June 3, 2020 AmorChem invests in the work of Sidong Huang at McGill University Read article

May 12, 2020 Consortium Backs Netherton Syndrome Project From Sinai Health Read article

February 24, 2020 AmorChem invests in a new gene therapy approach to help patients with a devastating orphan disease Read article

March 18, 2019 Announcement of Sweet 16 Selection for the 1st edition of Sweet Pharma Day Read article